首頁 > 市場調查報告書 > 醫療設備

體外診斷

皮膚切片檢查市場規模、佔有率及成長分析（按類型、適應症、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1904785

皮膚切片檢查市場規模、佔有率及成長分析（按類型、適應症、最終用戶和地區分類）－2026-2033年產業預測

Skin Biopsy Market Size, Share, and Growth Analysis, By Type (Shave Biopsy, Punch Biopsy), By Indication (Skin Cancer, Actinic Keratosis), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球皮膚切片檢查市場規模將達到 353.5 億美元，到 2025 年將達到 391.6 億美元，到 2033 年將達到 889.6 億美元，預測期（2026-2033 年）的複合年成長率為 10.8%。

由於新興市場醫療基礎設施的不斷改進、皮膚癌發病率的上升以及對先進醫療服務需求的成長，皮膚切片檢查市場預計將持續成長。皮膚切片檢查在診斷各種皮膚疾病（例如惡性黑色素瘤、皮膚炎和乾癬）方面發揮關鍵作用，從而推動了市場擴張。政府對醫療保健領域的投資不斷增加以及醫療旅遊的興起，進一步促進了開發中國家的市場成長。此外，對微創醫療程序的需求也不斷成長。目前已有針對100多種癌症的切片檢查方法，人口成長、疾病意識的提高以及醫療費用支出的增加等因素都在影響著市場。然而，高昂的手術費用和對創新技術的認知不足等挑戰可能會阻礙市場成長，但技術進步也帶來了新的機會。

全球皮膚切片檢查市場促進因素

由於人工智慧軟體的進步，全球皮膚切片檢查市場正經歷顯著成長。這些軟體能夠輔助病理學家高效分析切片檢查結果。這項創新技術簡化了診斷流程，減少了延誤，提高了市場效率。病理切片的數位化使得不同地區的病理學家和專家能夠進行無縫的遠端協作，從而促進影像和意見的共用。這種與專家的聯繫對於病理服務資源有限的地區尤其重要。因此，這些數位技術的融合正在推動皮膚切片檢查市場的整體成長。

限制全球皮膚切片檢查市場的因素

切片檢查手術的相關費用，包括術前評估和術後護理，對皮膚切片檢查市場的成長構成重大挑戰。中低收入者可能難以負擔這些費用，尤其是在醫療預算有限的地區，他們更難以負擔此類手術。這種經濟負擔導致人們在獲得基本醫療服務方面存在不平等，特別是對於那些沒有全面醫療保險的人來說。因此，經濟困難的人可能會推遲切片檢查，甚至錯過重要的診斷。解決這些不平等問題對於確保人人享有公平的醫療服務以及促進市場的整體發展至關重要。

全球皮膚切片檢查市場趨勢

全球皮膚切片檢查市場正呈現出顯著的趨勢，即醫療機構擴大採用綜合切片檢查技術，從而提高診斷準確性並改善患者照護。透過結合影像引導切片檢查、內視鏡檢查和分子分析等技術，醫療機構能夠從組織樣本中獲得更全面的資訊。這種多方面的方法有助於更深入地了解病理，使臨床醫生能夠做出更準確的診斷並制定個人化的治療方案。隨著醫療專業人員日益認知到這些先進調查方法的價值，對專用切片檢查設備的需求預計將強勁成長，這反映了整個行業向提升診斷能力的轉變。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Becton, Dickinson and Company（USA）
Cardinal Health（USA）
Boston Scientific Corporation（USA）
Cook Medical（USA）
Hologic, Inc.（USA）
Leica Biosystems Nussloch GmbH（Germany）
Danaher Corporation（USA）
Integra LifeSciences（USA）
Innovia Medical（USA）
DTR Medical Ltd（UK）
Gallini Srl（Italy）
KAI Group（Japan）
AccuTec, Inc.（USA）
Biomarker Technologies（China）
Vernacare（UK）
Freenome Holdings, Inc.（USA）
Biodesix（USA）
Exact Sciences Corporation（USA）
GRAIL, Inc.（USA）
GenMark Diagnostics（USA）

結論與建議

簡介目錄

Product Code: SQMIG35D2282

Global Skin Biopsy Market size was valued at USD 35.35 Billion in 2024 and is poised to grow from USD 39.16 Billion in 2025 to USD 88.96 Billion by 2033, growing at a CAGR of 10.8% during the forecast period (2026-2033).

The skin biopsy market is poised for growth driven by enhanced healthcare infrastructure in emerging markets, rising incidences of skin cancer, and heightened demand for advanced medical services. Skin biopsies serve as a pivotal diagnostic tool for various skin conditions, including melanoma, dermatitis, and psoriasis, fueling the market's expansion. Increasing government investments in healthcare, along with the rise of medical tourism, further support this growth in developing economies. Demand for less invasive medical procedures is also on the rise. With over 100 types of biopsies available for different cancers, factors such as population growth, disease awareness, and improving healthcare spending are influencing the market. Nevertheless, challenges like high procedural costs and limited awareness of innovative techniques may hinder growth, although technological advancements present new opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Skin Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Skin Biopsy Market Segments Analysis

Global Skin Biopsy Market is segmented by type, indication, end user and region. Based on type, the market is segmented into shave biopsy, punch biopsy and excisional biopsy. Based on indication, the market is segmented into skin cancer, actinic keratosis, dermatitis and others. Based on end user, the market is segmented into hospital, clinics, diagnostic laboratories and other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Skin Biopsy Market

The Global Skin Biopsy market is experiencing significant growth due to advancements in AI-powered software that assists pathologists in efficiently analyzing biopsy results. This innovative technology streamlines the diagnostic process, reducing delays and enhancing market efficiency. By enabling the digitization of pathology slides, it allows for seamless remote collaboration among pathologists and specialists, facilitating the sharing of images and opinions regardless of geographic limitations. Such connectivity to specialized expertise is particularly beneficial in areas with limited access to pathology services. As a result, the integration of these digital advancements is driving overall growth in the skin biopsy market.

Restraints in the Global Skin Biopsy Market

The costs associated with biopsy procedures, encompassing pre-surgical assessments and postoperative care, pose a significant challenge to the growth of the skin biopsy market. Individuals with low to moderate incomes often find these expenses prohibitively high, making it difficult for them to afford such procedures, especially in healthcare systems with limited budgets. This financial burden creates disparities in access to essential health services, particularly for those lacking comprehensive insurance coverage. Consequently, individuals with financial constraints may experience delays in obtaining biopsies or even miss critical diagnoses altogether. Addressing these inequities is crucial to ensure equitable access to healthcare and promote overall market development.

Market Trends of the Global Skin Biopsy Market

The global skin biopsy market is witnessing a significant trend towards the adoption of integrated biopsy methods within healthcare settings, enhancing both diagnostic precision and patient care. By leveraging a combination of techniques such as image-guided biopsies, endoscopic procedures, and molecular analysis, healthcare facilities are obtaining comprehensive insights from tissue samples. This multi-faceted approach facilitates a deeper understanding of pathologies, thereby enabling clinicians to provide more accurate diagnoses and tailored treatment plans. As healthcare professionals increasingly recognize the value of these advanced methodologies, the demand for specialized biopsy devices is expected to experience robust growth, reflecting a shift towards improved diagnostic capabilities across the industry.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Skin Biopsy Market Size by Type & CAGR (2026-2033)

Market Overview
Shave Biopsy
Punch Biopsy
Excisional Biopsy

Global Skin Biopsy Market Size by Indication & CAGR (2026-2033)

Market Overview
Skin Cancer
Actinic Keratosis
Dermatitis
Others

Global Skin Biopsy Market Size by End User & CAGR (2026-2033)

Market Overview
Hospital
Clinics
Diagnostic Laboratories
Other

Global Skin Biopsy Market Size & CAGR (2026-2033)

North America (Type, Indication, End User)
- US
- Canada
Europe (Type, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Indication, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leica Biosystems Nussloch GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innovia Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DTR Medical Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gallini Srl (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KAI Group (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AccuTec, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomarker Technologies (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vernacare (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Freenome Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biodesix (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exact Sciences Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GRAIL, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenMark Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments